Fidelity Enhanced Large Cap Value ETF (FELV)
NYSEARCA: FELV · IEX Real-Time Price · USD
28.99
-0.05 (-0.16%)
May 16, 2024, 3:59 PM EDT - Market closed
-0.16% (1D)
| Assets | $1.83B |
| Expense Ratio | 0.18% |
| PE Ratio | 17.78 |
| Shares Out | 63.48M |
| Dividend (ttm) | $0.27 |
| Dividend Yield | 0.94% |
| Ex-Dividend Date | Mar 15, 2024 |
| Payout Ratio | 16.71% |
| 1-Year Return | n/a |
| Volume | 281,600 |
| Open | 29.05 |
| Previous Close | 29.03 |
| Day's Range | 28.99 - 29.11 |
| 52-Week Low | 24.85 |
| 52-Week High | 29.27 |
| Beta | 0.66 |
| Holdings | 336 |
| Inception Date | Apr 19, 2007 |
About FELV
Fund Home PageThe Fidelity Enhanced Large Cap Value ETF (FELV) is an exchange-traded fund that mostly invests in large cap equity. The fund is actively managed, investing in large-cap value stocks belonging to a broad US equity value index. The fund aims for growth of capital FELV was launched on Apr 19, 2007 and is issued by Fidelity.
Asset Class Equity
Region North America
Stock Exchange NYSEARCA
Ticker Symbol FELV
ETF Provider Fidelity
Top 10 Holdings
18.95% of assets| Name | Symbol | Weight |
|---|---|---|
| Berkshire Hathaway Inc. | BRK.B | 3.82% |
| JPMorgan Chase & Co. | JPM | 3.22% |
| Exxon Mobil Corporation | XOM | 2.61% |
| Bank of America Corporation | BAC | 1.78% |
| Walmart Inc. | WMT | 1.44% |
| The Procter & Gamble Company | PG | 1.36% |
| Johnson & Johnson | JNJ | 1.25% |
| Merck & Co., Inc. | MRK | 1.18% |
| The Goldman Sachs Group, Inc. | GS | 1.15% |
| Pfizer Inc. | PFE | 1.14% |
